StageZero Life Sciences Ltd.
SZLSF
Price:
$0.0051
Market Cap:
$630.02K
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise focused on the development and commercialization of proprietary molecular diagnostic tests. These tests are primarily designed for the early detection of diseases and to facilitate personalized health management, with a particular emphasis on oncology-related conditions within the United States and Canada. At the core of their offerings is the proprietary Sentinel Principle platform technology, which specializes in identifying novel biomarkers from whole blood samples. The company's lead product, Aristotle, is an innovative multi-cancer panel test capable of simultaneously screening for numerous cancer types from a...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2009-09-08
Stock Exchange
OTC
Ticker
SZLSF
PE Ratio
[-0.04]
ROE
[481.50%]
Current Ratio
[0.04]
Dividend Yield
[0%]
Enterprise Value
[2.41M]
Dividend History
The PE Ratio as of June 2026 (TTM) for StageZero Life Sciences Ltd. (SZLSF) is -0.04
According to StageZero Life Sciences Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -98.09% compared to the average of -2.10 of the last 4 quarters.
StageZero Life Sciences Ltd. (SZLSF) Historical PE Ratio (quarterly & annually)
How has SZLSF PE Ratio performed in the past?
The mean historical PE Ratio of StageZero Life Sciences Ltd. over the last ten years is -0.96. The current -0.04 PE Ratio has changed 318.73% with respect to the historical average. Over the past ten years (40 quarters), SZLSF's PE Ratio was at its highest in in the June 2020 quarter at 24.63. The PE Ratio was at its lowest in in the June 2022 quarter at -4.06.
Average
-0.96
Median
-0.38
Minimum
-3.82
Maximum
-0.02
StageZero Life Sciences Ltd. (SZLSF) PE Ratio by Quarter and Year
Discovering the peaks and valleys of StageZero Life Sciences Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.68%
Maximum Annual PE Ratio = -0.02
Minimum Annual Increase = -98.71%
Minimum Annual PE Ratio = -3.82
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.39 | -82.25% |
| 2021 | -2.17 | -43.11% |
| 2020 | -3.82 | 1.66% |
| 2019 | -0.22 | 31.86% |
| 2018 | -0.16 | -75.81% |
| 2017 | -0.68 | 112.93% |
| 2016 | -0.32 | 1.68% |
| 2015 | -0.02 | -98.71% |
| 2014 | -1.40 | 273.05% |
| 2013 | -0.37 | 28.61% |
StageZero Life Sciences Ltd. (SZLSF) Average PE Ratio
How has SZLSF PE Ratio performed in the past?
The current PE Ratio of StageZero Life Sciences Ltd. (SZLSF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.13
5-year avg
-1.35
10-year avg
-0.96
StageZero Life Sciences Ltd. (SZLSF) PE Ratio vs. Peers
How is SZLSF’s PE Ratio compared to its peers?
StageZero Life Sciences Ltd.’s PE Ratio is greater than Medigene AG (-0.10), less than IDenta Corp. (3.39), less than ModivCare Inc. (-0.00), less than MJardin Group, Inc. (-0.00), greater than Epigenomics AG (-0.24), greater than Vaccinex, Inc. (-0.11), less than Cann American Corp. (0.18), less than InVitro International (18.80), greater than Anything Technologies Media, Inc. (-9.00), greater than Enzolytics Inc. (-7.39),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.10 | $38.17M | |
| 3.39 | $647.29K | |
| -0.00 | $215.31K | |
| -0.00 | $90.14K | |
| -0.24 | $982.21K | |
| -0.11 | $2.70M | |
| 0.18 | $1.62M | |
| 18.80 | $1.91M | |
| -9.00 | $2.16M | |
| -7.39 | $3.15M |
Build a custom stock screener for StageZero Life Sciences Ltd. (SZLSF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like StageZero Life Sciences Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
StageZero Life Sciences Ltd. (SZLSF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like StageZero Life Sciences Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is StageZero Life Sciences Ltd.'s PE Ratio?
How is the PE Ratio calculated for StageZero Life Sciences Ltd. (SZLSF)?
What is the highest PE Ratio for StageZero Life Sciences Ltd. (SZLSF)?
What is the 3-year average PE Ratio for StageZero Life Sciences Ltd. (SZLSF)?
What is the 5-year average PE Ratio for StageZero Life Sciences Ltd. (SZLSF)?
How does the current PE Ratio for StageZero Life Sciences Ltd. (SZLSF) compare to its historical average?